biostudies-literatureUnknown12Milosevic NParkes-Weber Syndrome is a rare congenital vascular abnormality characterized by aneurismatic illness of blood arteries in the afflicted limb, as well as hypertrophy, ulceration, ischemia, and high-output heart failure. Imaging investigations are required to provide a diagnosis, with contrast arteriography being the gold standard. The majority of treatment options are endovascular, with surgical excision for arteriovenous malformations and limb amputation as alternatives. We describe a 73-year-old male patient with mainly asymptomatic PWS, coronary disease, and borderline EF (45%) who had CABG surgery. In individuals with established CAD and other cardiac disorders, it is critical to identify additional diseases or syndromes that might have a compounding effect on the heart, such as PWS anFrontiers in cardiovascular medicine1479811https://www.ebi.ac.uk/biostudies/studies/S-EPMC12303869biostudies-literatureCase Report: The Parkes-Weber syndrome in the patient who underwent coronary surgery.PMC12303869Micovic SBojic MOkiljevic BZivkovic IMilosevic NfalseCase Report: The Parkes-Weber syndrome in the patient who underwent coronary surgery.Parkes-Weber Syndrome is a rare congenital vascular abnormality characterized by aneurismatic illness of blood arteries in the afflicted limb, as well as hypertrophy, ulceration, ischemia, and high-output heart failure. Imaging investigations are required to provide a diagnosis, with contrast arteriography being the gold standard. The majority of treatment options are endovascular, with surgical excision for arteriovenous malformations and limb amputation as alternatives. We describe a 73-year-old male patient with mainly asymptomatic PWS, coronary disease, and borderline EF (45%) who had CABG surgery. In individuals with established CAD and other cardiac disorders, it is critical to identify additional diseases or syndromes that might have a compounding effect on the heart, such as PWS an2025-01-01T00:00:00Z20252026-03-31T10:46:55.861Z2025-08-28T03:06:06.612ZS-EPMC123038694073498210.3389/fcvm.2025.1479811